Skip to content

Thursday, December 26, 2024

Latest:

You didn’t meet your goals for 2024. Now what?
Understanding the cascade of molecular events leading to Rett syndrome
The need for language inclusivity in clinical research
Caring for your feet with a diabetes diagnosis
Mapping functional relations among proteins and genes helps illuminate their role in cancer

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

TGF-β

Targeting TGF-β for treatment of osteogenesis imperfecta

March 22, 2022 brittle bone disease, fresolimumab, osteogenesis imperfecta, Research, TGF-β, treatment

A monoclonal antibody therapy that neutralizes TGF-β produced promising results in a Phase 1 clinical trial.

From the Labs: Image of the Month

From the Labs: Humans are complex genetic mosaics.

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951